Advancing Computational Toxicology in the Big Data Era by Artificial Intelligence: Data-Driven and Mechanism-Driven Modeling for Chemical Toxicity
- PMID: 30907586
- PMCID: PMC6688471
- DOI: 10.1021/acs.chemrestox.8b00393
Advancing Computational Toxicology in the Big Data Era by Artificial Intelligence: Data-Driven and Mechanism-Driven Modeling for Chemical Toxicity
Abstract
In 2016, the Frank R. Lautenberg Chemical Safety for the 21st Century Act became the first US legislation to advance chemical safety evaluations by utilizing novel testing approaches that reduce the testing of vertebrate animals. Central to this mission is the advancement of computational toxicology and artificial intelligence approaches to implementing innovative testing methods. In the current big data era, the terms volume (amount of data), velocity (growth of data), and variety (the diversity of sources) have been used to characterize the currently available chemical, in vitro, and in vivo data for toxicity modeling purposes. Furthermore, as suggested by various scientists, the variability (internal consistency or lack thereof) of publicly available data pools, such as PubChem, also presents significant computational challenges. The development of novel artificial intelligence approaches based on public massive toxicity data is urgently needed to generate new predictive models for chemical toxicity evaluations and make the developed models applicable as alternatives for evaluating untested compounds. In this procedure, traditional approaches (e.g., QSAR) purely based on chemical structures have been replaced by newly designed data-driven and mechanism-driven modeling. The resulting models realize the concept of adverse outcome pathway (AOP), which can not only directly evaluate toxicity potentials of new compounds, but also illustrate relevant toxicity mechanisms. The recent advancement of computational toxicology in the big data era has paved the road to future toxicity testing, which will significantly impact on the public health.
Conflict of interest statement
The authors declare no competing financial interest.
Figures



Similar articles
-
Big Data and Artificial Intelligence Modeling for Drug Discovery.Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:573-589. doi: 10.1146/annurev-pharmtox-010919-023324. Epub 2019 Sep 13. Annu Rev Pharmacol Toxicol. 2020. PMID: 31518513 Free PMC article. Review.
-
[AI-based QSAR Modeling for Prediction of Active Compounds in MIE/AOP].Yakugaku Zasshi. 2020;140(4):499-505. doi: 10.1248/yakushi.19-00190-4. Yakugaku Zasshi. 2020. PMID: 32238631 Review. Japanese.
-
Nonanimal Models for Acute Toxicity Evaluations: Applying Data-Driven Profiling and Read-Across.Environ Health Perspect. 2019 Apr;127(4):47001. doi: 10.1289/EHP3614. Environ Health Perspect. 2019. PMID: 30933541 Free PMC article.
-
Machine Learning and Artificial Intelligence in Toxicological Sciences.Toxicol Sci. 2022 Aug 25;189(1):7-19. doi: 10.1093/toxsci/kfac075. Toxicol Sci. 2022. PMID: 35861448 Free PMC article. Review.
-
Using a hybrid read-across method to evaluate chemical toxicity based on chemical structure and biological data.Ecotoxicol Environ Saf. 2019 Aug 30;178:178-187. doi: 10.1016/j.ecoenv.2019.04.019. Epub 2019 Apr 17. Ecotoxicol Environ Saf. 2019. PMID: 31004930 Free PMC article.
Cited by
-
Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling.Drug Discov Today. 2020 Sep;25(9):1624-1638. doi: 10.1016/j.drudis.2020.07.005. Epub 2020 Jul 11. Drug Discov Today. 2020. PMID: 32663517 Free PMC article. Review.
-
Editorial: Application of computational tools to health and environmental sciences, Volume II.Front Pharmacol. 2022 Dec 1;13:1102431. doi: 10.3389/fphar.2022.1102431. eCollection 2022. Front Pharmacol. 2022. PMID: 36532722 Free PMC article. No abstract available.
-
Advancing the Spatiotemporal Dimension of Wildlife-Pollution Interactions.Environ Sci Technol Lett. 2025 Mar 18;12(4):358-370. doi: 10.1021/acs.estlett.5c00042. eCollection 2025 Apr 8. Environ Sci Technol Lett. 2025. PMID: 40224496 Free PMC article. Review.
-
Big Data and Artificial Intelligence Modeling for Drug Discovery.Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:573-589. doi: 10.1146/annurev-pharmtox-010919-023324. Epub 2019 Sep 13. Annu Rev Pharmacol Toxicol. 2020. PMID: 31518513 Free PMC article. Review.
-
Machine Learning Toxicity Prediction: Latest Advances by Toxicity End Point.ACS Omega. 2022 Dec 13;7(51):47536-47546. doi: 10.1021/acsomega.2c05693. eCollection 2022 Dec 27. ACS Omega. 2022. PMID: 36591139 Free PMC article. Review.
References
-
- Stouch TR, Kenyon JR, Johnson SR, Chen XQ, Doweyko A, and Li Y (2003) In Silico ADME/Tox: Why Models Fail. J. Comput.-Aided Mol. Des 17 (2–4), 83–92. - PubMed
-
- Maggiora GM (2006) On Outliers and Activity Cliffs - Why QSAR Often Disappoints. J. Chem. Inf. Model 46 (4), 1535. - PubMed
-
- Dearden JC, Cronin MTD, and Kaiser KLE (2009) How Not to Develop a Quantitative Structure-Activity or Structure-Property Relationship (QSAR/QSPR). SAR QSAR Environ. Res 20 (3–4), 241–266. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources